Intra Cellular Therapies | L'Utile Operativo



Operating Profit Cambiamento Data
Acadia Pharmaceuticals USD 153.5M 121.86M 2024-12
ALKERMES USD 162.69M 57.93M 2024-12
Biogen USD 441.4M 24.4M 2024-12
Bristol-Myers Squibb USD 793M 1.39B 2024-12
Cytokinetics USD -139040000 1.76M 2024-12
Gilead Sciences USD 2.45B 1.56B 2024-12
Halozyme Therapeutics USD 175.5M 12.3M 2024-12
Intra Cellular Therapies USD -29197000 9.65M 2024-12
J&J USD 3.89B 549M 2024-12
Neurocrine Biosciences USD 142M 41.8M 2024-12
Novartis USD 3.4B 193M 2024-12
Prothena USD -64897000 1.62M 2024-12
RedHill Biopharma USD -4220000 1.8M 2024-06
Supernus Pharmaceuticals USD 21.4M 19.44M 2024-12
United Therapeutics USD 357.7M 14.6M 2024-12



Intra Cellular Therapies L'Utile Operativo - Valori correnti, dati storici, previsioni, statistiche, grafici e calendario economico - Mar 2025.